Detalhe da pesquisa
1.
Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma.
J Oncol Pharm Pract
; 28(3): 686-690, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037773
2.
Comparison of two different intravenous serotonin antagonists used for chemotherapy-induced nausea and vomiting prophylaxis in patients treated with moderately emetogenic risk regimens: A retrospective analysis from a large academic medical center.
J Oncol Pharm Pract
; 26(8): 1964-1969, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32633661
3.
Evaluation of fosaprepitant-associated hypersensitivity reactions at a National Cancer Center.
J Oncol Pharm Pract
; 26(6): 1369-1373, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31955703
4.
Pilot Prehabilitation Program for Patients With Esophageal Cancer During Neoadjuvant Therapy and Surgery.
J Surg Res
; 235: 66-72, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30691852
5.
Apalutamide: A new agent in the management of prostate cancer.
J Oncol Pharm Pract
; 25(8): 1968-1978, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31359832
6.
Geriatric assessments and medication management in elderly oncology patients.
Consult Pharm
; 32 Suppl B: 1-20, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29022689
7.
Geriatric Assessments and Medication Therapy Management Approaches in Elderly Oncology Patients.
Consult Pharm
; 32(2): 1-20, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28760173
8.
Immune checkpoint inhibitors: Significant advancements in non-small cell lung cancer treatment.
Am J Health Syst Pharm
; 78(9): 769-780, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580648
9.
Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors.
Clin Cancer Res
; 26(17): 4633-4642, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414750
10.
Gemtuzumab Ozogamicin: Back Again.
J Adv Pract Oncol
; 10(1): 68-82, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31308990
11.
A Review of PI3K Inhibitors in B-Cell Malignancies.
J Adv Pract Oncol
; 10(7): 715-725, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-33391855
12.
Ublituximab for the treatment of CD20 positive B-cell malignancies.
Expert Opin Investig Drugs
; 27(4): 407-412, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29609506
13.
Clinical pharmacy academic career transitions: Viewpoints from the field.
Curr Pharm Teach Learn
; 10(2): 121-122, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706263
14.
Clinical pharmacy academic career transitions: Viewpoints from the fieldPart 1: Understanding feedback, evaluation, and advancement.
Curr Pharm Teach Learn
; 10(2): 123-127, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706264
15.
Clinical pharmacy academic career transitions: Viewpoints from the field part 3: Learning when and how to say yes.
Curr Pharm Teach Learn
; 10(2): 133-136, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706266
16.
Collaboration Leads to Oral Chemotherapy Education.
J Adv Pract Oncol
; 9(7): 755-756, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-31249723
17.
Rising Cost of Cancer Pharmaceuticals: Cost Issues and Interventions to Control Costs.
Pharmacotherapy
; 37(1): 85-93, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27862122
18.
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics.
Cancer Manag Res
; 8: 49-55, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27274310
19.
Antibody-Drug Conjugates: A Clinical Pharmacy Perspective on an Emerging Cancer Therapy.
Pharmacotherapy
; 36(1): 99-116, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26799352
20.
Heart failure caused by molecularly targeted therapies for cancer.
Pharmacotherapy
; 31(1): 62-75, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21182360